(Q44461837)

3 December 2017

title

Myeloid clonogenic assays for comparison of the in vitro toxicity of alkylating agents (English)

1 reference

3 December 2017

Volpe DA

1

1 reference

3 December 2017

Warren MK

series ordinal

2

1 reference

3 December 2017

publication date

1 June 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

17

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

271-277

1 reference

Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myeloma

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2803%2900012-2

7 January 2021

In vitro toxicity of 3′‐azido‐3′‐deoxythymidine, carbovir and 2′, 3′‐didehydro‐2′, 3′‐dideoxythymidine to human and murine haematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2803%2900012-2

7 January 2021

Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2803%2900012-2

7 January 2021

Estimation of the haematological toxicity of minor groove alkylators using tests on human cord blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2803%2900012-2

7 January 2021

Differential toxicity of anticancer drugs on late (GM-CFC) and early (LTC-IC) hemopoietic progenitors in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2803%2900012-2

7 January 2021

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2803%2900012-2

7 January 2021

Clinical pharmacokinetics of oral CCNU (lomustine)

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2803%2900012-2

7 January 2021

Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2803%2900012-2

7 January 2021

Chemotherapy-induced myelosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2803%2900012-2

7 January 2021

Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2803%2900012-2

7 January 2021

In vitro and in vivo myelotoxicity of CAI to human and murine hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2803%2900012-2

7 January 2021

Myelotoxicity of rifabutin and 3'-azido-3'-deoxythymidine, alone and in combination, to human hematopoietic progenitor cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2803%2900012-2

7 January 2021

Comparative in vitro myelotoxicity of FCE 24517, a distamycin derivative, to human, canine and murine hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2803%2900012-2

7 January 2021

Myelotoxic effects of the bifunctional alkylating agent bizelesin on human, canine and murine myeloid progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-2333%2803%2900012-2

7 January 2021

10.1016/S0887-2333(03)00012-2

Identifiers

DOI

1 reference

3 December 2017

1 reference